These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 1199668

  • 1. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z, Heyrovský A, Volek V.
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [Abstract] [Full Text] [Related]

  • 2. [True hepatic Wilson's disease].
    Ciravegna B, Giacchino R, Marazzi MG.
    Pediatr Med Chir; 1983 Oct; 5(1-2):7-10. PubMed ID: 6634446
    [Abstract] [Full Text] [Related]

  • 3. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F.
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L, Sturniolo GC, Giacon G, Montino MC, Lecis PE, Schade RR, Corazza GR, Trevisan C, Naccarato R.
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [Abstract] [Full Text] [Related]

  • 6. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R, Kaur G, Walia BN.
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S, Martines D, Irato P, Sturniolo GC.
    J Clin Gastroenterol; 2006 Nov; 40(10):936-41. PubMed ID: 17063115
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ, Hill GM, Dick RD, Nostrant TT, Sams JS, Wells JJ, Prasad AS.
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [Abstract] [Full Text] [Related]

  • 9. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S, Samuelson G, Sjölin S.
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract] [Full Text] [Related]

  • 10. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A, Damato VD, Germinario L, Campanella G, Boccuni N.
    Acta Neurol (Napoli); 1971 Feb; 26(4):436-48. PubMed ID: 5132825
    [No Abstract] [Full Text] [Related]

  • 11. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM.
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [Abstract] [Full Text] [Related]

  • 12. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, Mabuchi H, Kono S, Miyajima H.
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [Abstract] [Full Text] [Related]

  • 13. [Experiences with penicillamine in Wilson's disease].
    Lössner J, Bachmann H, Eichner B.
    Psychiatr Neurol Med Psychol Beih; 1975 Nov; 20-21():48-53. PubMed ID: 829635
    [Abstract] [Full Text] [Related]

  • 14. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K, Hanka R, Walshe JM.
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [Abstract] [Full Text] [Related]

  • 15. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'Incà R, Irato P, Burra P, Martines D, Sturniolo GC.
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [Abstract] [Full Text] [Related]

  • 16. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
    Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G.
    Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
    [Abstract] [Full Text] [Related]

  • 17. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J, Brandt G.
    Med Welt; 1981 Jan 16; 32(3):109-10. PubMed ID: 7207132
    [No Abstract] [Full Text] [Related]

  • 18. Wilson's disease (hepatolenticular degeneration).
    Herron BE.
    Ophthalmic Semin; 1976 Jan 16; 1(1):63-9. PubMed ID: 1023089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D, Slavícek J, Hartl J, Seidlová V, Komenda S.
    Vnitr Lek; 1970 Apr 16; 16(4):344-53. PubMed ID: 5443326
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.